Thus, the identification of frequent variants in BRCA1/2 genes will enable implementation of rapid, inexpensive population‐specific BRCA1/2 genetic testing, particularly for triple‐negative BC patients known for their high prevalence in Tanzania. The gene discussed is BRCA1; the disease is breast cancer.